RUNX1 and hematologic disorder: A better understanding of Runx1 regulation may yield insights into potential avenues for therapeutic targeting of RUNX1 in a variety of hematological disorders, as recently highlighted by growth inhibition in a leukemia cell line upon loss of the Runx1+ 23 enhancer22.